Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
Our brain is big on team work makes the dream work. Not only brain cells, but even smaller units that make up a cell work in cooperation to make the brain work properly.
Cells make a lot of trash. Probably more than you’d think. So, cells have a trash disposal system that efficiently cleans up and recycles any waste that is produced. But when there are issues with the disposal system and trash builds up in the cell, that can lead to disease. This has led researchers to consider the trash disposal system as a target for potential disease treatments and therapies.
Professor of Comparative Biosciences at the School of Veterinary Medicine and Waisman Center investigator, John Svaren, PhD, is a recipient of a Vilas Distinguished Professorship.
CMT is a slowly progressive disease in contrast to ALS, which affects the same neurons in the peripheral nervous system.
Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease, and retinitis pigmentosa all have different manifestations and affect different body functions, but they are all connected by one mechanism: neurodegeneration.
John Svaren, professor of Comparative Biosciences at the School of Veterinary Medicine and director of the Waisman Center IDD Models Core, has been named the interim Associate Vice Chancellor for Research in the Biological Sciences.
AI collects big data and uses computer algorithms to search patterns that are present in your daily life.
When nerves are injured, Schwann cells—a key cell in peripheral nerve function and nerve insulation—assume a new role and identity as repair cells.
A new test may spur advances in drug discovery for a rare and debilitating neurological disorder. Charcot-Marie-Tooth disease, a rare inherited neurological disorder, affects more than 2.8 million people around the globe.
A new study from the lab of UW-Madison professor of medicine Luigi Puglielli, MD, PhD, opens a door to potential treatments for diseases of age, such as Alzheimer’s disease, by defining the roles of two enzymes that are imperative to protein production.
